Sad kitten!
(aka, 404 — not found)
It happens to all of us. In this case, it just means
you tried to visit a page that doesn't exist (yet).
Click on the logo up top to go back to the home page.
Yes, we’re reviewing that ‘demonstrably difficult’ proposed rule
It’s been breathlessly anticipated for months, and this week it finally published: an FDA proposed rule regarding the Demonstrably Difficult to Compound list. read more →
10 days left to apply for APC Fellowship
Since the program’s inception in 1997, 162 professionals have been honored as APC Fellows. read more →
Wedgewood is APC’s newest Silver-level supporter
Long-time APC supporter Wedgewood Pharmacy, a compounder focused exclusively on animal health, is our newest 2024 Silver-level Corporate Patron. read more →
FDA wants to issue guidance docs without public comment
In a draft report and plan for guidance documents released by FDA earlier this year, the agency indicated that it intends to issue guidance documents without a public notice and comment period. read more →
Damned if we do, damned if we don’t
Let’s say you’re APC. You get a call from a producer at a major news network saying that their celebrity medical doctor is doing a story on GLP-1 drugs and wants to include compounded GLP-1s in the piece. read more →
APC Fellowship deadline is March 31
The deadline to apply for 2024 induction is March 31, so review the information on the APC Fellows webpage and start your application now. The induction will take place at APC’s Compounders on Capitol Hill event in September. read more →
There are a half-dozen “big deals” that APC will announce in the next three weeks, every one of them focused one way or another on assuring patient access, pharmacy/facility compliance, and practice efficiency. read more →
OMB concludes review of FDA ‘demonstrably difficult’ proposed rule
OMB concluded their review of FDA’s proposed rule on Drug Products That Present Demonstrable Difficulties for Compounding Under Sections 503A and 503B of the Federal Food Drug and Cosmetic Act and returned it with changes. read more →
Federal appeals court accepts our amicus brief
The U.S. Court of Appeals for the Fifth Circuit has accepted an amicus brief filed by APC in the case Zyla Life Sciences v. Wells Pharma. read more →
CONTACT US
E-mail: info@a4pc.org
Phone: (281) 933-8400
Fax: (281) 495-0602
Mailing: Alliance for Pharmacy Compounding
100 Daingerfield Road, Ste. 100
Alexandria, VA 22314
APC is committed to addressing any concerns or complaints within one business day. Please send them — and, of course, any compliments — to info@a4pc.org.
THE APC FAMILY